(Q52047809)

20 April 2018

title

Interactions of excitatory amino acid antagonists with conventional antiepileptic drugs. (English)

1 reference

20 April 2018

author

Waldemar A. Turski

series ordinal

2

1 reference

20 April 2018

Zdzisław Kleinrok

series ordinal

3

object named as

Z Kleinrok

1 reference

20 April 2018

Stanisław Jerzy Czuczwar

series ordinal

1

object named as

S J Czuczwar

1 reference

20 April 2018

publication date

1 June 1996

1 reference

20 April 2018

published in

Metabolic Brain Disease

1 reference

20 April 2018

volume

11

1 reference

20 April 2018

issue

2

1 reference

20 April 2018

page(s)

143-152

1 reference

20 April 2018

https://scigraph.springernature.com/pub.10.1007/bf02069501

exact match

0 references

cites work

The role of glutamate in neurotransmission and in neurologic disease

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02069501

Metabotropic glutamate receptors: synaptic transmission, modulation, and plasticity.

21 January 2018

1 reference

12 December 2020

Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine

1 reference

12 December 2020

Competitive NMDA receptor antagonists enhance the antielectroshock activity of various antiepileptics

1 reference

12 December 2020

Relief of experimental spasticity and anxiolytic/anticonvulsant actions of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline

1 reference

12 December 2020

Properties of vertebrate glutamate receptors: calcium mobilization and desensitization

1 reference

12 December 2020

Differential effects of antiepileptic drugs and beta-carbolines on seizures induced by excitatory amino acids

1 reference

12 December 2020

Brain lesions in an infant rhesus monkey treated with monsodium glutamate

1 reference

12 December 2020

Excitatory amino acid receptors and synaptic plasticity

1 reference

12 December 2020

Acidic amino acids with strong excitatory actions on mammalian neurones

1 reference

12 December 2020

Effects of excitatory amino-acid antagonists on the anticonvulsant action of phenobarbital or diphenylhydanton in mice

1 reference

12 December 2020

Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists

1 reference

12 December 2020

Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists

1 reference

12 December 2020

2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia.

1 reference

12 December 2020

Antiparkinsonian drugs memantine and trihexyphenidyl potentiate the anticonvulsant activity of valproate against maximal electroshock-induced seizures

1 reference

12 December 2020

Evaluation of CPP, a selective NMDA antagonist, in various rodent models of epilepsy. Comparison with other NMDA antagonists, and with diazepam and phenobarbital.

1 reference

12 December 2020

The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents

1 reference

12 December 2020

A new model of focal status epilepticus: intra-amygdaloid application of kainic acid elicits repetitive secondarily generalized convulsive seizures

1 reference

12 December 2020

Antiepileptic drug development program: a cooperative effort of government and industry

1 reference

12 December 2020

Prevention of kainic acid-induced seizure-like activity by antiepileptic drugs.

1 reference

12 December 2020

Potent oral anticonvulsant action of CPP and CPPene in DBA/2 mice

1 reference

12 December 2020

The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy

1 reference

12 December 2020

Valproate suppresses N-methyl-D-aspartate-evoked, transient depolarizations in the rat neocortex in vitro

1 reference

12 December 2020

The NMDA antagonist procyclidine, but not ifenprodil, enhances the protective efficacy of common antiepileptics against maximal electroshock-induced seizures in mice

1 reference

12 December 2020

2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline enhances the protective activity of common antiepileptic drugs against maximal electroshock-induced seizures in mice.

1 reference

12 December 2020

Influence of combined treatment with NMDA and non-NMDA receptor antagonists on electroconvulsions in mice

1 reference

12 December 2020

Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acid

1 reference

12 December 2020

Epilepsy and the concentrations of plasma amino acids in humans

1 reference

12 December 2020

Chemical Excitation of Spinal Neurones

1 reference

12 December 2020

Modulation of the seizure threshold for excitatory amino acids in mice by antiepileptic drugs and chemoconvulsants.

1 reference

12 December 2020

Phenytoin blocks N-methyl-D-aspartate responses of mouse central neurons.

1 reference

12 December 2020

Amino acid transmitters in the mammalian central nervous system

1 reference

12 December 2020

Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy

1 reference

12 December 2020

Glutamate: A Neurotransmitter in Mammalian Brain

1 reference

12 December 2020

Is amygdala kindling in rats a model for drug-resistant partial epilepsy?

1 reference

12 December 2020

The competitive NMDA antagonist, D-CPP-ene, potentiates the anticonvulsant activity of conventional antiepileptics against maximal electroshock-induced seizures in mice.

1 reference

12 December 2020

Phosphonic analogues of excitatory amino acids raise the threshold for maximal electroconvulsions in mice

1 reference

12 December 2020

Glutamate antagonists have different effects on spontaneous locomotor activity in rats.

1 reference

12 December 2020

Influence of a Ca2+ channel agonist, Bay k-8644, on the anticonvulsant activity of NMDA and non-NMDA receptor antagonists

1 reference

12 December 2020

The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics.

1 reference

12 December 2020

Cloned glutamate receptors

1 reference

12 December 2020

Anticonvulsant action of excitatory amino acid antagonists

1 reference

12 December 2020

Competitive antagonists of NMDA receptors, CGP 37849 and CGP 39551, enhance the anticonvulsant activity of valproate against electroconvulsions in mice.

1 reference

12 December 2020

Antagonism of N-methyl-D,L-aspartic acid-induced convulsions by antiepileptic drugs and other agents

1 reference

12 December 2020

Anticonvulsant activity of the NMDA antagonists, D(-)4-(3-phosphonopropyl) piperazine-2-carboxylic acid (D-CPP) and D(-)(E)-4-(3-phosphonoprop-2-enyl) piperazine-2-carboxylic acid (D-CPPene) in a rodent and a primate model of reflex epilepsy

1 reference

12 December 2020

Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists.

1 reference

12 December 2020

Excitatory amino acid antagonists protect mice against seizures induced by bicuculline.

1 reference

12 December 2020

Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks

1 reference

12 December 2020

Effects of anticonvulsants and other agents on seizures induced by intracerebral l-glutamate

1 reference

12 December 2020

Influence of MK-801 on the anticonvulsant activity of antiepileptics.

1 reference

12 December 2020

Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02069501

1 reference

20 April 2018

1 reference

20 April 2018